He is a board-certified (ABPP-CN) clinical neuropsychologist who investigates the neuropsychological consequences of substance use disorders. Dr. Dean is the recipient of a K23 career award which aims to relate cognitive decline in methamphetamine-dependent individuals to abnormalities in brain structure as assessed through structural MRI. He is the course master for the Seminar in Addiction Psychiatry (Psychiatry 434), a lecture course broadly covering the biological, genetic and psychosocial foundations of addiction. Dr. Dean also directs the Center for Addictive Behaviors (CAB) Neuropsychology Practicum which trains clinical psychology graduate students in the neuropsychological assessment of addictive disorders. Publications: